Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
70.78
-0.54 (-0.76%)
At close: Nov 12, 2025, 4:00 PM EST
70.78
0.00 (0.00%)
After-hours: Nov 12, 2025, 4:20 PM EST
Mirum Pharmaceuticals Market Cap
Mirum Pharmaceuticals has a market cap or net worth of $3.64 billion as of November 12, 2025. Its market cap has increased by 92.84% in one year.
Market Cap
3.64B
Enterprise Value
3.56B
1-Year Change
92.84%
Ranking
Category
Stock Price
$70.78
Market Cap Chart
Since July 18, 2019, Mirum Pharmaceuticals's market cap has increased from $297.23M to $3.64B, an increase of 1,123.86%. That is a compound annual growth rate of 48.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2025 | 3.64B | 83.26% |
| Dec 31, 2024 | 1.98B | 44.25% |
| Dec 29, 2023 | 1.38B | 91.51% |
| Dec 30, 2022 | 718.54M | 47.79% |
| Dec 31, 2021 | 486.19M | -4.80% |
| Dec 31, 2020 | 510.71M | -7.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 887.33B |
| Johnson & Johnson | 464.39B |
| AbbVie | 396.39B |
| UnitedHealth Group | 293.81B |
| AstraZeneca | 275.02B |
| Novartis AG | 243.29B |
| Merck & Co. | 224.47B |
| Abbott Laboratories | 220.58B |